Stay updated on TAK-659 in AML Clinical Trial
Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.

Latest updates to the TAK-659 in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe NIH announcement banner about the transition from “Artificial Intelligence” to “Super Intelligence” is no longer displayed. The clinical trial page continues to show a 403 error.SummaryDifference1%

- Check15 days agoChange DetectedThe site footer revision label updates from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide NIH notice was added, linking to transition updates and explaining that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.” The study record remains unavailable behind a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error for the study record NCT02323113, blocking access to the study details.SummaryDifference20%

Stay in the know with updates to TAK-659 in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.